An interventional study of Bilateral Erector Spinae Plane (ESP) Block and Standard Postoperative Analgesia in Postoperative Pain and Open Abdominal Surgery, sponsored by Fatima Memorial Hospital. Active, not recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-03-18.
Sponsored by Fatima Memorial Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 137 studies in Pain, Postoperative with a site in Pakistan — 41 open to participants now, 45 under way, 5 of them phase 3. Pain, Postoperative · Pakistan.
Among the 137 studies in Pain, Postoperative with a site in Pakistan, this one is the 125th largest by enrollment of the 135 interventional ones that give a count, is one of 29 that started in 2025, is one of 86 with no phase, reaches primary completion later than 13 of the 44 other live ones, and was the 100th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →41 of the 137 studies in Pain, Postoperative with a site in Pakistan are open now. Recruiting first, the newest first:
Khyber Medical University Peshawar · Sites in Pakistan
Ages 18–40 · Healthy volunteers
Shaukat Khanum Memorial Cancer Hospital & Research Centre · Sites in Pakistan
Ages 18+
Wah Medical college , POF hospital · Sites in Pakistan
Ages 18–60
King Edward Medical University · Sites in Pakistan
Ages 18–60
Quaid-e-Azam Medical College · Sites in Pakistan
Ages 1–15
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
137 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 12 · Phase 2 13 · Phase 3 13 · Phase 4 20
First in 2014; this study’s year is marked. 29 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 46 is below the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 78 across the 135 interventional studies, 60 across the 2 observational. Of the 77 that completed or were terminated, 3 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 137 has an industry lead sponsor. The 10 most frequent:
Fatima Memorial Hospital is the lead sponsor of 12 studies on the registry; 3 are open to participants now.
Fatima Memorial Hospital has 6 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
16 of the studies in Pain, Postoperative with a site in Pakistan that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06996561Phase 3Dr. Asma Abdus SalamExploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management | 2027-01-01 |
| NCT07779551Sargodha Medical CollegeComparison of Two Drugs Bupivacaine and Ropivacaine for Postoperative Analgesia in Bilateral Superficial Cervical Plexus Block After Thyroidectomy | 2026-12 |
| NCT07650760Wah Medical college , POF hospitalComparison of Intraperitoneal Bupivacaine and Saline Irrigation for Pain Relief After Laparoscopic Cholecystectomy | 2026-12 |
| NCT07775053Sargodha Medical CollegeEfficacy of Tramadol With Ropivacaine for Modified Pectoral Nerve Block in Breast Cancer Surgery | 2026-12-31 |
| NCT07338006University of Health Sciences LahoreChest Wall Reconstruction Cohort | 2026-12-31 |
Add all 16 to your calendar (.ics) → With an account.
Among the 137 studies in Pain, Postoperative with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
his randomized controlled trial aims to evaluate the efficacy of the bilateral erector spinae plane (ESP) block in reducing postoperative opioid consumption in patients undergoing open abdominal surgeries under general anesthesia
Patients undergoing abdominal surgeries experience severe postoperative pain. Conventional pain management methods, including opiates, may pose significant side effects. This study addresses the imperative need for optimizing postoperative pain management by systematically investigating the analgesic effects and complications associated with the bilateral ESP block. The study involves 46 patients allocated into two groups using a lottery method: a control group receiving standard pain control treatment, and an erector spinae block group receiving a bilateral ESP block in addition to standard pain control treatment. Pain intensity will be evaluated using a visual analogue scale (VAS) at 4, 8, 12, and 24 hours after the operation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients receiving standard pain control treatment. Postoperatively, patients receive 1000 mg of IV paracetamol every 6 hours. If a patient reports a Visual Analogue Score (VAS) exceeding five, they will receive rescue analgesia consisting of nalbuphine 4mg
Drug: Standard Postoperative Analgesia
Patients receiving bilateral ESP block in addition to standard pain control treatment
Procedure: Bilateral Erector Spinae Plane (ESP) Block · Drug: Standard Postoperative Analgesia
Administered after the induction of general anesthesia and before the surgical incision. Local anesthetic (0.25% ropivacaine or 0.25% bupivacaine) will be injected for a total of 20-40 mL
Patients receive 1000 mg of IV paracetamol every 6 hours postoperatively. If a patient experiences a Visual Analogue Score (VAS) of more than five at any time, they receive rescue analgesia in the form of nalbuphine 4mg
Postoperative Opioid Consumption
Assessed by the percentage of patients requiring rescue opioid analgesia. The need for rescue analgesia is determined by a Visual Analogue Score (VAS) greater than five
Time frame: Within the first 24 hours after surgery
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2025 (actual). Primary completion is estimated for Mar 2026, 5 months after the start.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 5 months is below that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fatima Memorial Hospital